Dovitinib Dilactic acid (TKI258 Dilactic acid)
Catalog No. A10198
Dovitinib是一种小分子多靶点酪氨酸激酶抑制剂,可抑制通过ZNF198-FGFR1或BCR-FGFR1转化为IL3独立性的Ba / F3细胞,IC50值分别为150 nM和90 nM。
Catalog Num | A10198 |
---|---|
M. Wt | 572.6 |
Formula | C21H21FN6O.2C3H6O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 852433-84-2 |
Synonyms | CHIR-258, TKI258 |
SMILES | CC(C(=O)O)O.CC(C(=O)O)O.CN1CCN(CC1)C2=CC3=C(C=C2)N/C(=C/4\C(=C5C(=NC4=O)C=CC=C5F)N)/N3 |
Dovitinib是一种小分子多靶点酪氨酸激酶抑制剂,可抑制通过ZNF198-FGFR1或BCR-FGFR1转化为IL3独立性的Ba / F3细胞,IC50值分别为150 nM和90 nM。
Targets
Target | Value |
---|---|
FLT3 | IC50: 1nM |
c-Kit | IC50: 2nM |
FGFR1 | IC50: 8nM |
VEGFR3/FLT4 | IC50: 8nM |
FGFR3 | IC50: 9nM |
VEGFR1/FLT1 | IC50: 10nM |
VEGFR2/Flk1 | IC50: 13nM |
PDGFRβ | IC50: 27nM |
CSF-1R/c-Fms | IC50: 36nM |
PDGFRα | IC50: 210nM |
Insulin Receptor | IC50: 2μM |
EGFR | IC50: 2μM |
c-Met | IC50: >3μM |
EphA2 | IC50: 4μM |
Tie-2 | IC50: 4μM |
IGF-1R | IC50: >10μM |
HER2 | IC50: >10μM |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 17.46 mL | 87.32 mL | 174.64 mL |
0.5 mM | 3.49 mL | 17.46 mL | 34.93 mL |
1 mM | 1.75 mL | 8.73 mL | 17.46 mL |
5 mM | 0.35 mL | 1.75 mL | 3.49 mL |
*The above data is based on the productmolecular weight 572.6. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.